Annual General Meeting

Approval of all Agenda Items

The Annual General Meeting approved the actions of the Executive Board and the Supervisory Board of Merck KGaA, Darmstadt, Germany for fiscal 2021 and approved all of the resolutions on the agenda, including the proposed dividend of € 1.85 per share, an increase of € 0.45 over the previous year.

  • Webcast of the AGM 2022

    On the occasion of our AGM 2022, we recorded a webcast of the statements by the Chairman of the Supervisory Board, Wolfgang Büchele, and the report of the CEO Belén Garijo.
    Webcast
  • Presence & voting results

    Here you will find the presence and voting results.
    Read more
  • Speech by the CEO

    Speech by Belén Garijo, Chair of the Executive Board and CEO of Merck KGaA, Darmstadt, Germany. (Check against delivery).
    Read the speech

Documents for the annual general meeting of Merck KGaA, Darmstadt, Germany on 22 April 2022

    Download
  Dividend announcement PDF
  Information in accordance with Table 8 of the Regulation (EU) 2018/1212 PDF
  Presence and Voting Results PDF
  Invitation for the Annual General Meeting of Merck KGaA, Darmstadt, Germany on 22 April 2022

PDF (English)

PDF (German)

  Explanation of shareholder rights

PDF (English)

PDF (German)

  Information on Data Privacy for Shareholders PDF
  Articles of association of Merck KGaA, Darmstadt, Germany PDF
  Sample of the agenda voting card PDF
  Competence-matrix for Supervisory Board candidates PDF
  Overview of auditor rotation PDF
  Overview GL Compensation PDF (English)
PDF (German)
  Annual report of Merck KGaA, Darmstadt, Germany for the fiscal year 2021 including the consolidated financial statements, combined Management report and Supervisory Board report PDF
  Single entity financial statements of Merck KGaA, Darmstadt, Germany for the fiscal year 2021 including the combined Management report and Supervisory Board report PDF
  Explanations on the submission of statements

PDF (English)

PDF (German)

  Information relating to agenda item 9 (Cancellation of the current authorized capital and the creation of new authorized capital) PDF
  Information in accordance with Section 125 of the German Stock Corporation Act (AktG) in conjunction with the Implementing Regulation (EU) 2018/1212

PDF (English)

PDF (German)

  Speech by Belén Garijo, Chair of the Executive Board and CEO of Merck KGaA, Darmstadt, Germany.
(Pre-released April 11, 2022. Check against delivery.)
PDF

Related News

View All News
  1. Press Releases

    Annual General Meeting: Approval of all Agenda Items

    The Annual General Meeting approved the actions of the Executive Board and the Supervisory Board of Merck KGaA, Darmstadt, Germany, for fiscal 2021 and approved all of the resolutions on the agenda, ...

    2022/04/22

  • Annual Report 2021

    Group delivered record growth in fiscal 2021. All three business sectors, first and foremost Life Science, contributed to sales growth.
    Read more
  • Sustainability Report

    We transparently inform our stakeholders about our activities and successes, along with the challenges we face. Every year, we publish a comprehensive report.
    Read more

Previous Annual General Meetings

Annual General Meeting Archive

Archived documents for the past annual general meetings

Read More